Precision BioSciences (NASDAQ: DTIL) reported Q2 EPS of ($0.19), $0.40 better than the analyst estimate of ($0.59). Revenue for the quarter came in at $24 million versus the consensus estimate of $6.02 million.

For earnings history and earnings-related data on Precision BioSciences (DTIL) click here.